Offer - Urjas Oil for just ₹ 1 X
Budamate 400 Transhaler is a prescription drug, available for use as Inhaler. It is typically used for the treatment of Asthma. Budamate 400 Transhaler also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Budamate 400 Transhaler. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Budamate 400 Transhaler include Nasopharyngitis, Headache, Back Pain. Besides the aforementioned side effects, there are other adverse effects of Budamate 400 Transhaler as well, which are listed below. Such side effects of Budamate 400 Transhaler normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Budamate 400 Transhaler's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Budamate 400 Transhaler's effects on the liver, heart and kidney, if any, have been listed below.
The section on Budamate 400 Transhaler contraindications lists all such conditions.
Additionally, Budamate 400 Transhaler may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Budamate 400 Transhaler is safe while driving, and is is addictive in nature.
Budamate 400 Transhaler is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Budamate 400 Transhaler safe for pregnant women?
Pregnant women may experience moderate side effects from Budamate. It is best to stop taking Budamate immediately and inform your doctor if you notice any discomfort.
Is the use of Budamate 400 Transhaler safe during breastfeeding?
Budamate may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Budamate, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Budamate.
What is the effect of Budamate 400 Transhaler on the Kidneys?
There are no side effects of Budamate on the kidneys.
What is the effect of Budamate 400 Transhaler on the Liver?
Budamate is completely safe for the liver.
What is the effect of Budamate 400 Transhaler on the Heart?
Budamate has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Budamate 400 Transhaler unless your doctor advises you to do so -
Is this Budamate 400 Transhaler habit forming or addictive?
Budamate 400 Transhaler does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Budamate 400 Transhaler will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Budamate 400 Transhaler is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Budamate 400 Transhaler for mental disorders.
Interaction between Food and Budamate 400 Transhaler
It is safe to take Budamate 400 Transhaler with food.
Interaction between Alcohol and Budamate 400 Transhaler
Consult your doctor before consuming alcohol while taking Budamate 400 Transhaler as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca